These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25736819)

  • 1. Cilostazol research in Asia: can it be applied to European and American patients?
    Kim JS; Kwon SU; Uchiyama S
    Int J Stroke; 2015 Mar; 10 Suppl 1():1-9. PubMed ID: 25736819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cilostazol for secondary stroke prevention: an old dog with new tricks?
    Ansara AJ; Shiltz DL; Slavens JB
    Ann Pharmacother; 2012 Mar; 46(3):394-402. PubMed ID: 22353234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol: a drug particularly effective for Asians?
    Kim JS; Shinohara Y
    Int J Stroke; 2011 Jun; 6(3):209-10. PubMed ID: 21557806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol in secondary prevention of stroke: impact of the Cilostazol Stroke Prevention Study.
    Matsumoto M
    Atheroscler Suppl; 2005 Dec; 6(4):33-40. PubMed ID: 16275125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
    Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
    Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding.
    Goto S
    Atheroscler Suppl; 2005 Dec; 6(4):3-11. PubMed ID: 16275169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
    Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
    Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
    Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
    Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
    Qian Y; Bi Q
    Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
    Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
    J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis.
    Wang W; Zhang L; Liu W; Zhu Q; Lan Q; Zhao J
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1081-1089. PubMed ID: 26856461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials.
    Uchiyama S; Demaerschalk BM; Goto S; Shinohara Y; Gotoh F; Stone WM; Money SR; Kwon SU
    J Stroke Cerebrovasc Dis; 2009; 18(6):482-90. PubMed ID: 19900653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis.
    McHutchison C; Blair GW; Appleton JP; Chappell FM; Doubal F; Bath PM; Wardlaw JM
    Stroke; 2020 Aug; 51(8):2374-2385. PubMed ID: 32646330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
    Shi L; Pu J; Xu L; Malaguit J; Zhang J; Chen S
    BMC Neurol; 2014 Dec; 14():251. PubMed ID: 25527141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of cilostazol versus aspirin for the secondary prevention of stroke.
    Dinicolantonio JJ; Lavie CJ; Fares H; Menezes AR; O'Keefe JH; Bangalore S; Messerli FH
    Am J Cardiol; 2013 Oct; 112(8):1230-4. PubMed ID: 23827403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cilostazol in the management of atherosclerosis.
    Sallustio F; Rotondo F; Di Legge S; Stanzione P
    Curr Vasc Pharmacol; 2010 May; 8(3):363-72. PubMed ID: 20180773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
    Uchiyama S
    Rinsho Shinkeigaku; 2010 Nov; 50(11):832-4. PubMed ID: 21921460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: protective effects of antiplatelet agents against stroke.
    Shimazawa M; Hara H
    J Pharmacol Sci; 2011; 116(1):30-5. PubMed ID: 21498958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.